Skip to content

Author

Dileep R. Reddy

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract A013: Preclinical Development of a Humanized CD44v9-Directed Antibody-Drug Conjugate for Treatment-Refractory Breast Cancer

Preclinical development of a humanized CD44v9-directed ADC for advanced breast cancer after resistance to existing ADCs is supported, with results reproduced the activity observed in earlier chimeric proof-of-concept studies.

N. Ueno, Dileep R. Reddy, McKenna E. Flynn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.